X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs PANACEA BIOTECH - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA PANACEA BIOTECH SANOFI INDIA/
PANACEA BIOTECH
 
P/E (TTM) x 30.0 81.4 36.8% View Chart
P/BV x 5.3 1.8 292.9% View Chart
Dividend Yield % 1.7 0.0 -  

Financials

 SANOFI INDIA   PANACEA BIOTECH
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
PANACEA BIOTECH
Mar-14
SANOFI INDIA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs4,560149 3,066.6%   
Low Rs4,40082 5,346.3%   
Sales per share (Unadj.) Rs1,028.584.1 1,222.3%  
Earnings per share (Unadj.) Rs129.0-18.3 -704.4%  
Cash flow per share (Unadj.) Rs186.0-6.7 -2,776.3%  
Dividends per share (Unadj.) Rs68.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs753.683.7 900.3%  
Shares outstanding (eoy) m23.0361.25 37.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.41.4 317.3%   
Avg P/E ratio x34.7-6.3 -550.6%  
P/CF ratio (eoy) x24.1-17.2 -139.7%  
Price / Book Value ratio x5.91.4 430.8%  
Dividend payout %52.70-   
Avg Mkt Cap Rs m103,1747,074 1,458.4%   
No. of employees `0003.62.8 131.7%   
Total wages/salary Rs m3,5921,449 247.9%   
Avg. sales/employee Rs Th6,537.71,874.1 348.8%   
Avg. wages/employee Rs Th991.4527.0 188.1%   
Avg. net profit/employee Rs Th819.8-407.7 -201.0%   
INCOME DATA
Net Sales Rs m23,6865,154 459.6%  
Other income Rs m708100 709.4%   
Total revenues Rs m24,3945,254 464.3%   
Gross profit Rs m5,281-766 -689.2%  
Depreciation Rs m1,313711 184.7%   
Interest Rs m151,503 1.0%   
Profit before tax Rs m4,661-2,881 -161.8%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m1,69117 10,065.5%   
Profit after tax Rs m2,970-1,121 -264.9%  
Gross profit margin %22.3-14.9 -149.9%  
Effective tax rate %36.3-0.6 -6,220.5%   
Net profit margin %12.5-21.8 -57.6%  
BALANCE SHEET DATA
Current assets Rs m15,6733,810 411.3%   
Current liabilities Rs m6,6788,365 79.8%   
Net working cap to sales %38.0-88.4 -43.0%  
Current ratio x2.30.5 515.3%  
Inventory Days Days76156 48.8%  
Debtors Days Days2267 33.2%  
Net fixed assets Rs m8,09814,480 55.9%   
Share capital Rs m23061 375.7%   
"Free" reserves Rs m17,088903 1,892.2%   
Net worth Rs m17,3565,127 338.5%   
Long term debt Rs m05,832 0.0%   
Total assets Rs m25,40019,433 130.7%  
Interest coverage x311.7-0.9 -34,013.4%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.90.3 351.6%   
Return on assets %11.82.0 598.3%  
Return on equity %17.1-21.9 -78.2%  
Return on capital %26.93.6 740.9%  
Exports to sales %24.524.5 99.9%   
Imports to sales %28.010.2 274.8%   
Exports (fob) Rs m5,8011,264 459.0%   
Imports (cif) Rs m6,627525 1,262.8%   
Fx inflow Rs m7,1451,539 464.2%   
Fx outflow Rs m6,846942 726.8%   
Net fx Rs m299597 50.1%   
CASH FLOW
From Operations Rs m3,226599 538.4%  
From Investments Rs m-1,555-438 355.1%  
From Financial Activity Rs m-1,818-303 600.8%  
Net Cashflow Rs m-147-141 104.0%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 0.6 2,400.0%  
FIIs % 14.6 1.3 1,123.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 23.6 44.5%  
Shareholders   15,184 10,259 148.0%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   FULFORD INDIA  SUVEN LIFE  CIPLA  WOCKHARDT LTD.  VENUS REMEDIES  

Compare SANOFI INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Aug 21, 2017 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - PFIZER COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS